Simcere Pharmaceutical Group Limited
2096
Clasificación en acciones
#4480
Simcere Pharmaceutical Group Limited is a Chinese entity engaged in the... Simcere Pharmaceutical Group Limited is a Chinese entity engaged in the comprehensive process of discovering, developing, manufacturing, and commercializing pharmaceutical products. These medicines are distributed to various clients, including distributors, pharmacy chains, and fellow drug manufacturers within China. The company strategically focuses on a diverse range of therapeutic areas, notably oncology, central nervous system conditions, autoimmune diseases, anti-infective treatments, and cardiovascular health, among others. Its extensive product portfolio features key medications such as Sanbexin (an edaravone and dexborneol concentrated solution for injection), Endostar (a recombinant human endostatin injection), ENWEIDA (an envafolimab injection), Softan (rosuvastatin calcium tablets), ZAILIN (amoxicillin in granules, dispersible tablets, or capsules), Iremod (iguratimod tablets), Antine (diclofenac sodium sustained-release capsules or gel), and Orencia (an abatacept injection). Additionally, Simcere offers specialized promotional services for pharmaceutical goods. Demonstrating its commitment to innovation, the group has established a strategic regional licensing collaboration with Vivoryon Therapeutics N.V. This partnership aims to develop and commercialize novel therapies for Alzheimer's disease by targeting the neurotoxic amyloid protein N3pE (pGlu-Aß). Established in 1995, Simcere Pharmaceutical Group Limited is headquartered in Nanjing, China.
Precio por acción
$1.32
Capitalización bursátil
$3.40B
Cambio (1 día)
-4.51%
Cambio (1 año)
-19.88%
País
CN
Comercio Simcere Pharmaceutical Group Limited (2096)
Categoría
Healthcare
Número de acciones en circulación de Simcere Pharmaceutical Group Limited (2096)
Número de acciones en circulación al October 2026: 0
Según los últimos informes financieros y el precio de las acciones de Simcere Pharmaceutical Group Limited, el número actual de acciones en circulación es 0. Al final de October 2026, la empresa tenía 0 acciones en circulación. El número de acciones en circulación generalmente se ve afectado por divisiones de acciones y recompras.
Historial de acciones en circulación de Simcere Pharmaceutical Group Limited (2096) desde 2012 hasta 2026
Acciones en circulación al final de cada año
| Año | Acciones en circulación | Cambiar |
|---|---|---|
| 2025 | 2.49B | -1.25% |
| 2024 | 2.52B | -3.39% |
| 2023 | 2.61B | -0.10% |
| 2022 | 2.61B | 0.10% |
| 2021 | 2.61B | 0.00% |
| 2020 | 2.61B | 0.11% |
| 2019 | 2.61B | 0.00% |
| 2018 | 2.61B | 0.00% |
| 2017 | 2.61B | 2,326.81% |
| 2012 | 107.37M | 0.00% |
Acciones en circulación de empresas similares o competidores
| Empresa | Acciones en circulación | Diferencia | País |
|---|---|---|---|
| 253.90M | - |
US
|
|
| 396.00M | - |
US
|
|
| 478.91M | - |
AU
|
|
| 62.19M | - |
NL
|
|
| 0.00 | - |
BE
|
